What makes tesamorelin stand out clinically is that its active peptide was FDA-validated through EGRIFTA SV, the brand-name drug approved specifically for excess visceral fat in HIV patients with lipodystrophy
Claim Boundaries for RUO Product-Page Copy The key research boundary is simple
doi:10.3390/molecules191119066 Vukojevic J, Milavi M, Perovi D, et al
The idea is that these ingredients are absorbed through the skin and help boost your metabolism, reduce cravings, or support your bodys natural production of the GLP-1 hormone
These adaptations may explain why metabolic benefits can continue to improve over weeks to months of consistent use, rather than plateauing immediately
The most notable finding was that the weight loss was specifically fat loss, particularly in the abdominal area